Collaborator: Merck Research Laboratories

• Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer

  Abstract Importance Performing DNA genetic testing (DGT) for hereditary cancer genes is now a well-accepted clinical practice; however, the interpretation of DNA variation remains a challenge for laboratories and clinicians. Adding RNA genetic testing (RGT) enhances DGT by clarifying the clinical actionability of hereditary cancer gene variants, thus improving clinicians’ ability to accurately apply strategies…